Company intelligence / Profile preview
Kinnear Pharmaceuticals
Dublin, Ohio, United States
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Kinnear Pharmaceuticals is a preclinical-stage biotech developing Ceragenin-based therapies targeting severe infectious and inflammatory diseases with high unmet need. Their lead candidate, CSA‑131, recently received FDA Qualified Infectious Disease Product (QIDP) designation for the prevention and treatment of life-threatening Pseudomonas infections in cystic fibrosis patients. The company’s approach leverages synthetic mimics of innate immune system peptides to overcome limitations of natural antimicrobials such as stability and manufacturability. No clinical results have been published yet; programs remain at the discovery/preclinical stage
- Therapeutic areas
- GastroenterologyOncologyPulmonologyInfectious Diseases
- Modalities
- Small molecules (specifically Ceragenins, which are synthetic non-peptide mimetics of host defense peptides)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Cystic Fibrosis Foundation Therapeutics (grant funding)Brigham Young University (technology origin/licensing)
Beyond the preview
Go deeper on Kinnear Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kinnear Pharmaceuticals.